13F Data
13F filer · CIK 2013410

FCPM III SERVICES B.V.

NAARDEN, P7 · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$750.4M
+$28.2M vs prior
Positions
11
New / sold out
1 / 0
Added / reduced
0 / 2
Turnover
3.9%
buys $28.8M · sells $41.7M
Top-10 weight
99.9%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewAURA BIOSCIENCES INC+4,053,775–+$28.8M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedNEWAMSTERDAM PHARMA COMPANY-708,547-7.7%$-24.0M
ReducedDYNE THERAPEUTICS INC-796,130-17.1%$-17.7M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2023: $339.4MQ1 2024: $707.3MQ2 2024: $678.1MQ3 2024: $582.3MQ4 2024: $592.4MQ1 2025: $413.7MQ2 2025: $369.2MQ3 2025: $500.4MQ4 2025: $762.9MQ1 2026: $722.2MQ2 2026: $750.4M
Q4 2023Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES8,490,353$287.7M38.34%
2MAPLIGHT THERAPEUTICS INCCOM3,226,400$115.6M15.41%
3DYNE THERAPEUTICS INCCOM3,848,256$85.5M11.39%
4VOR BIOPHARMA INCCOM NEW4,117,354$75.8M10.10%
5DAMORA THERAPEUTICS INCCOM NEW2,441,000$63.5M8.46%
6REPLIMUNE GROUP INCCOM2,808,368$31.1M4.14%
7CRESCENT BIOPHARMA INC.COM1,677,852$30.2M4.02%
8AURA BIOSCIENCES INCCOM4,053,775$28.8M3.84%
9ENGENE HOLDINGS INCCOM9,632,561$16.7M2.22%
10BICYCLE THERAPEUTICS PLCSPONSORED ADS3,468,430$14.7M1.96%
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.